Invest
Stock Update: Biosensors Receives CE Mark Approval for BioMatrix NeoFlex™
By SG Wealth Builder  •  May 21, 2013
Below is a press release from Biosensors. SG Web Reviews has been monitoring the company for quite sometimes and is of the opinion that Biosensor has a lot of potential to grow. Just like Apple, Biosensors has the ability to cannabalise its older products, which is a hallmark of a forward-looking innovative companies. Not vested in this counter.

Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, has announced CE Mark approval for BioMatrix NeoFlex™, the latest addition to the BioMatrix family of drug-eluting stents (DES). BioMatrix NeoFlex features a new advanced stent delivery system, improving pushability, trackability and crossability. It also has a lower lesion entry profile than its predecessor.

BioMatrix NeoFlex retains the same unique combination of abluminal biodegradable polymer coating, proprietary limus drug Biolimus A9™ (BA9™) and flexible platform which has made the BioMatrix stent family an ...
...
Read the full article
By SG Wealth Builder
Welcome to SG Wealth Builder! My name is Gerald and I hope that you find this blog useful in your wealth building journey. The motto of this blog is “to make money, to build wealth and to preserve wealth” ...
LEAVE A COMMENT
LEAVE A COMMENT

Your email address will not be published.

*

Your Email Address will not be published
*

Read More Articles
More from thefinance